Home » Newsletters » BioWorld Science

BioWorld Science

June 5, 1998

View Archived Issues

Evaluation of rolipram in experimental animal models of colitis

Cantab: Q1 1998 highlights

Vertex updates shareholders at annual meeting

Xechem receives notice of allowance for paclitaxel analogues

Milkhaus granted U.S. patent for amyloid plaque-reducing agent

Company Profile: InKine

Unimed granted patent coverage for dronabinol use as dementia therapy

Fenofibrate capsules now available in U.S.

Ditropan XL effectively controls urge incontinence in phase III trial

FDA approves PrefGel for periodontal surgery preparation

Zyrtec approved for use in children as young as two years

Genzyme Molecular Oncology and Dana-Farber agreement for fusion cell technology

Pharmacological profile of a selective ETA antagonist

Valaciclovir reduces opportunistic infections in transplant recipients

Amylin: Q1 1998 highlights

Lilly initiates clinical development of tomoxetine for ADHD

Novel series of 5-HT1F agonists under study at Lilly

Cryptophycins for cancer, fungal infections described in patent literature

Synthelabo discloses new agents for urinary incontinence

Series of dopamine receptor subtype-selective ligands developed at Pfizer

Fujisawa compounds lower blood cholesterol, triglyceride and lipid levels

Reversal of diabetes-induced cardiac fibrosis with pirfenidone obtained in animal model

Candesartan reduces infarct size in pig model of myocardial ischemia

LU-302872, an orally active ETA/ETB antagonist for the treatment of BPH

Cardioprotective properties found for pranidipine, a long-acting Ca antagonist

Preclinical and clinical profile of lercanidipine detailed at recent congress

FDA advisory committee recommends approval of new indication for Hycamtin

Teijin expands overseas to support development of TEI-6720

Clinical protocol for phase I/II testing of tgAAV-CFTR

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...